Evidence map›Paper›PMID 24465735›Full record

ArticlePloS one2014

Btk regulates macrophage polarization in response to lipopolysaccharide.

Joan Ní Gabhann, Emily Hams, Siobhán Smith, Claire Wynne, Jennifer C Byrne, Kiva Brennan, Shaun Spence, Adrien Kissenpfennig, James A Johnston, Padraic G Fallon and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 134 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Current and future landscape of Bruton tyrosine kinase inhibitors in allergy.The Journal of allergy and clinical immunology · 2025
    Review
  5. Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Inhibition of BTK and SYK attenuatesJournal of oral microbiology · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis.Therapeutic advances in neurological disorders · 2024
    Review
  14. Article
  15. Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series.Pathobiology : journal of immunopathology, molecular and cellular biology · 2024
    Article
  16. Review
  17. A Review on Role of Inflammation in Coronavirus Disease.Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Joan Ní GabhannMolecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland.
Emily HamsTrinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Siobhán SmithMolecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland.
Claire WynneMolecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland ; School of Biological Sciences, Dublin Institute of Technology, Kevin St, Dublin, Ireland.
Jennifer C ByrneMolecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland.
Kiva BrennanTrinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Shaun SpenceCentre for Infection and Immunity, School of Medicine Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
Adrien KissenpfennigCentre for Infection and Immunity, School of Medicine Dentistry and Biomedical Sciences, Queen's University, Belfast, United Kingdom.
James A JohnstonAmgen Inc., Thousand Oaks, California, United States of America.
Padraic G FallonTrinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland ; Institute of Molecular Medicine, St. James's Hospital, Trinity College Dublin, Dublin, Ireland ; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
Caroline A JefferiesMolecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland.
Royal College of Surgeons in Ireland · IEQueen's University Belfast · GBTrinity College Dublin · IEAmgen (United States) · USSt. James's Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages to the classic inflammatory M1 population. Given the role of Btk as a critical signal transducer downstream of TLR4, we investigated its role in M1/M2 induction. In Btk deficient (Btk (-\-)) mice we observed markedly reduced recruitment of M1 macrophages following intraperitoneal administration of LPS. Ex vivo analysis demonstrated an impaired ability of Btk(-/-) macrophages to polarize into M1 macrophages, instead showing enhanced induction of immunosuppressive M2-associated markers in response to M1 polarizing stimuli, a finding accompanied by reduced phosphorylation of STAT1 and enhanced STAT6 phosphorylation. In addition to STAT activation, M1 and M2 polarizing signals modulate the expression of inflammatory genes via differential activation of transcription factors and regulatory proteins, including NF-κB and SHIP1. In keeping with a critical role for Btk in macrophage polarization, we observed reduced levels of NF-κB p65 and Akt phosphorylation, as well as reduced induction of the M1 associated marker iNOS in Btk(-/-) macrophages in response to M1 polarizing stimuli. Additionally enhanced expression of SHIP1, a key negative regulator of macrophage polarisation, was observed in Btk(-/-) macrophages in response to M2 polarizing stimuli. Employing classic models of allergic M2 inflammation, treatment of Btk (-/-) mice with either Schistosoma mansoni eggs or chitin resulted in increased recruitment of M2 macrophages and induction of M2-associated genes. This demonstrates an enhanced M2 skew in the absence of Btk, thus promoting the development of allergic inflammation.

Indexed as

Agammaglobulinaemia Tyrosine KinaseAnimalsCell PolarityHypersensitivityInflammationLipopolysaccharidesMacrophagesMacrophages, PeritonealMiceMice, Inbred C57BLModels, BiologicalPhenotypePhosphorylationProtein-Tyrosine KinasesSignal TransductionToll-Like Receptor 4Agammaglobulinaemia Tyrosine KinaseLipopolysaccharidesProtein-Tyrosine KinasesTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID24465735
PMCPMC3897530
OpenAlexW2155712529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.